Skip to main content

CORRECTION article

Front. Pharmacol., 11 January 2018
Sec. Experimental Pharmacology and Drug Discovery
Volume 8 - 2017 | https://doi.org/10.3389/fphar.2017.00991

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR

This article is a correction to:

  1. Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR

    1. Read original article
\r\nJiachao GuoJiachao Guo1Weijin LiWeijin Li1Yingxing WuYingxing Wu2Xingzhi JingXingzhi Jing1Junming HuangJunming Huang1Jiaming ZhangJiaming Zhang1Wei XiangWei Xiang1Ranyue RenRanyue Ren1Zhengtao LvZhengtao Lv1Jun Xiao*Jun Xiao1*Fengjing Guo*Fengjing Guo1*
  • 1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 2Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

A corrigendum on
Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR

by Guo, J., Li, W., Wu, Y., Jing, X., Huang, J., Zhang, J., et al. (2017). Front. Pharmacol. 8:693. doi: 10.3389/fphar.2017.00693

There is an error in the Funding statement. The correct number for 81372915 is 81371915. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: meclizine, PXR, osteoclast, RANKL, osteoporosis

Citation: Guo J, Li W, Wu Y, Jing X, Huang J, Zhang J, Xiang W, Ren R, Lv Z, Xiao J and Guo F (2018) Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR. Front. Pharmacol. 8:991. doi: 10.3389/fphar.2017.00991

Received: 09 December 2017; Accepted: 22 December 2017;
Published: 11 January 2018.

Edited and reviewed by: Maria Angela Sortino, Università degli Studi di Catania, Italy

Copyright © 2018 Guo, Li, Wu, Jing, Huang, Zhang, Xiang, Ren, Lv, Xiao and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jun Xiao, jun_xiao@hust.edu.cn
Fengjing Guo, guofjdoc@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.